RAF Inhibitors Activate the MAPK Pathway by Relieving Inhibitory Autophosphorylation
Holderfield, Matthew, Merritt, Hanne, Chan, John, Wallroth, Marco, Tandeske, Laura, Zhai, Huili, Tellew, John, Hardy, Stephen, Hekmat-Nejad, Mohammad, Stuart, Darrin D., McCormick, Frank, Nagel, Tobi E.
Published in Cancer cell (13.05.2013)
Published in Cancer cell (13.05.2013)
Get full text
Journal Article
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Das Thakur, Meghna, Salangsang, Fernando, Landman, Allison S., Sellers, William R., Pryer, Nancy K., Levesque, Mitchell P., Dummer, Reinhard, McMahon, Martin, Stuart, Darrin D.
Published in Nature (London) (14.02.2013)
Published in Nature (London) (14.02.2013)
Get full text
Journal Article
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma
Delord, Jean-Pierre, Robert, Caroline, Nyakas, Marta, McArthur, Grant A, Kudchakar, Ragini, Mahipal, Amit, Yamada, Yasuhide, Sullivan, Ryan, Arance, Ana, Kefford, Richard F, Carlino, Matteo S, Hidalgo, Manuel, Gomez-Roca, Carlos, Michel, Daniela, Seroutou, Abdelkader, Aslanis, Vassilios, Caponigro, Giordano, Stuart, Darrin D, Moutouh-de Parseval, Laure, Demuth, Tim, Dummer, Reinhard
Published in Clinical cancer research (15.09.2017)
Published in Clinical cancer research (15.09.2017)
Get full text
Journal Article
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
Monaco, Kelli-Ann, Delach, Scott, Yuan, Jing, Mishina, Yuji, Fordjour, Paul, Labrot, Emma, McKay, Daniel, Guo, Ribo, Higgins, Stacy, Wang, Hui Qin, Liang, Jinsheng, Bui, Karen, Green, John, Aspesi, Peter, Ambrose, Jessi, Mapa, Felipa, Griner, Lesley, Jaskelioff, Mariela, Fuller, John, Crawford, Kenneth, Pardee, Gwynn, Widger, Stephania, Hammerman, Peter S, Engelman, Jeffrey A, Stuart, Darrin D, Cooke, Vesselina G, Caponigro, Giordano
Published in Clinical cancer research (01.04.2021)
Published in Clinical cancer research (01.04.2021)
Get full text
Journal Article
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science
Stuart, Darrin D., Guzman-Perez, Angel, Brooijmans, Natasja, Jackson, Erica L., Kryukov, Gregory V., Friedman, Adam A., Hoos, Axel
Published in Cancer discovery (05.10.2023)
Published in Cancer discovery (05.10.2023)
Get full text
Journal Article
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target
Chen, Guo, Chakravarti, Nitin, Aardalen, Kimberly, Lazar, Alexander J, Tetzlaff, Michael T, Wubbenhorst, Bradley, Kim, Sang-Bae, Kopetz, Scott, Ledoux, Alicia A, Gopal, Y N Vashisht, Pereira, Cristiano Goncalves, Deng, Wanleng, Lee, Ju-Seog, Nathanson, Katherine L, Aldape, Kenneth D, Prieto, Victor G, Stuart, Darrin, Davies, Michael A
Published in Clinical cancer research (01.11.2014)
Published in Clinical cancer research (01.11.2014)
Get full text
Journal Article
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma
Leung, Grace P, Feng, Tianshu, Sigoillot, Frederic D, Geyer, Felipe C, Shirley, Matthew D, Ruddy, David A, Rakiec, Daniel P, Freeman, Alyson K, Engelman, Jeffrey A, Jaskelioff, Mariela, Stuart, Darrin D
Published in Molecular cancer research (01.01.2019)
Published in Molecular cancer research (01.01.2019)
Get full text
Journal Article
STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts
Buckbinder, Leonard, St Jean, Jr, David J, Tieu, Trang, Ladd, Brendon, Hilbert, Brendan, Wang, Weixue, Alltucker, Jacob T, Manimala, Samantha, Kryukov, Gregory V, Brooijmans, Natasja, Dowdell, Gregory, Jonsson, Philip, Huff, Michael, Guzman-Perez, Angel, Jackson, Erica L, Goncalves, Marcus D, Stuart, Darrin D
Published in Cancer discovery (01.11.2023)
Published in Cancer discovery (01.11.2023)
Get full text
Journal Article
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
Hao, Huai-Xiang, Wang, Hongyun, Liu, Chen, Kovats, Steven, Velazquez, Roberto, Lu, Hengyu, Pant, Bhavesh, Shirley, Matthew, Meyer, Matthew J, Pu, Minying, Lim, Joanne, Fleming, Michael, Alexander, LeighAnn, Farsidjani, Ali, LaMarche, Matthew J, Moody, Susan, Silver, Serena J, Caponigro, Giordano, Stuart, Darrin D, Abrams, Tinya J, Hammerman, Peter S, Williams, Juliet, Engelman, Jeffrey A, Goldoni, Silvia, Mohseni, Morvarid
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging
Liu, Xiaohui, Ide, Jennifer L., Norton, Isaiah, Marchionni, Mark A., Ebling, Maritza C., Wang, Lan Y., Davis, Erin, Sauvageot, Claire M., Kesari, Santosh, Kellersberger, Katherine A., Easterling, Michael L., Santagata, Sandro, Stuart, Darrin D., Alberta, John, Agar, Jeffrey N., Stiles, Charles D., Agar, Nathalie Y. R.
Published in Scientific reports (04.10.2013)
Published in Scientific reports (04.10.2013)
Get full text
Journal Article
Design and Discovery of N‑(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the Clinic
Ramurthy, Savithri, Taft, Benjamin R, Aversa, Robert J, Barsanti, Paul A, Burger, Matthew T, Lou, Yan, Nishiguchi, Gisele A, Rico, Alice, Setti, Lina, Smith, Aaron, Subramanian, Sharadha, Tamez, Victoriano, Tanner, Huw, Wan, Lifeng, Hu, Cheng, Appleton, Brent A, Mamo, Mulugeta, Tandeske, Laura, Tellew, John E, Huang, Shenlin, Yue, Qin, Chaudhary, Apurva, Tian, Hung, Iyer, Raman, Hassan, A. Quamrul, Mathews Griner, Lesley A, La Bonte, Laura R, Cooke, Vesselina G, Van Abbema, Anne, Merritt, Hanne, Gampa, Kalyani, Feng, Fei, Yuan, Jing, Mishina, Yuji, Wang, Yingyun, Haling, Jacob R, Vaziri, Sepideh, Hekmat-Nejad, Mohammad, Polyakov, Valery, Zang, Richard, Sethuraman, Vijay, Amiri, Payman, Singh, Mallika, Sellers, William R, Lees, Emma, Shao, Wenlin, Dillon, Michael P, Stuart, Darrin D
Published in Journal of medicinal chemistry (12.03.2020)
Published in Journal of medicinal chemistry (12.03.2020)
Get full text
Journal Article
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
Ettenberg, Seth A., Charlat, Olga, Daley, Michael P., Liu, Shanming, Vincent, Karen J., Stuart, Darrin D., Schuller, Alwin G., Yuan, Jing, Ospina, Beatriz, Green, John, Yu, Qunyan, Walsh, Renee, Li, Sharon, Schmitz, Rita, Heine, Holger, Bilic, Sanela, Ostrom, Lance, Mosher, Rebecca, Hartlepp, K. Felix, Zhu, Zhenping, Fawell, Stephen, Yao, Yung-Mae, Stover, David, Finan, Peter M., Porter, Jeffery A., Sellers, William R., Klagge, Ingo M., Cong, Feng, Nusse, Roeland
Published in Proceedings of the National Academy of Sciences - PNAS (31.08.2010)
Published in Proceedings of the National Academy of Sciences - PNAS (31.08.2010)
Get full text
Journal Article
RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation
Crowe, Matthew S, Zavorotinskaya, Tatiana, Voliva, Charles F, Shirley, Matthew D, Wang, Yanqun, Ruddy, David A, Rakiec, Daniel P, Engelman, Jeffery A, Stuart, Darrin D, Freeman, Alyson K
Published in Molecular cancer research (01.06.2021)
Published in Molecular cancer research (01.06.2021)
Get full text
Journal Article
Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
Han, Wooseok, Ding, Yu, Xu, Yongjin, Pfister, Keith, Zhu, Shejin, Warne, Bob, Doyle, Mike, Aikawa, Mina, Amiri, Payman, Appleton, Brent, Stuart, Darrin D, Fanidi, Abdallah, Shafer, Cynthia M
Published in Journal of medicinal chemistry (14.04.2016)
Published in Journal of medicinal chemistry (14.04.2016)
Get full text
Journal Article
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype
Paraiso, Kim H T, Das Thakur, Meghna, Fang, Bin, Koomen, John M, Fedorenko, Inna V, John, Jobin K, Tsao, Hensin, Flaherty, Keith T, Sondak, Vernon K, Messina, Jane L, Pasquale, Elena B, Villagra, Alejandro, Rao, Uma N, Kirkwood, John M, Meier, Friedegund, Sloot, Sarah, Gibney, Geoffrey T, Stuart, Darrin, Tawbi, Hussein, Smalley, Keiran S M
Published in Cancer discovery (01.03.2015)
Published in Cancer discovery (01.03.2015)
Get full text
Journal Article
RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors
YINGJUN SU, VILGELM, Anna E, ZAJA-MILATOVIC, Snjezana, BROWN DAHLMAN, Kimberly, AMIRI, Katayoun I, AIXIANG JIANG, PENGCHENG LU, YU SHYR, STUART, Darrin D, SHAWN LEVY, SOSMAN, Jeffrey A, RICHMOND, Ann, KELLEY, Mark C, HAWKINS, Oriana E, YAN LIU, BOYD, Kelli L, KANTROW, Sara, SPLITTGERBER, Ryan C, SHORT, Sarah P, SOBOLIK, Tammy
Published in Clinical cancer research (15.04.2012)
Published in Clinical cancer research (15.04.2012)
Get full text
Journal Article